Stocks Telegraph

AQST Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:AQST

Aquestive Therapeutics, Inc.

$5.08
-0.1209-2.33%
Open: 3:56 PM
70.55
BESG ScoreESG Rating

AQST FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

AQST Income Statement


A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
revenue20.099M12.053M13.206M13.002M13.241M
cost of revenue4.526M4.389M4.679M4.798M6.617M
gross profit15.573M7.664M8.527M8.204M6.624M
gross profit ratio0.7750.6360.6460.6310.50
research and development expenses4.162M5.932M2.888M3.196M3.473M
general and administrative expenses00000
selling and marketing expenses00000
selling general and administrative expenses11.356M10.689M9.55M7.385M7.36M
other expenses00000
operating expenses15.518M16.621M12.438M10.581M10.833M
cost and expenses20.044M21.01M17.117M15.379M17.45M
interest income1.395M329.00K165.00K1.514M129.00K
interest expense4.195M4.20M3.235M-1.256M1.428M
depreciation and amortization205.00K207.00K467.00K263.00K289.00K
ebitda260.00K-8.75M-3.444M-2.377M-3.791M
ebitda ratio0.013-0.726-0.261-0.183-0.286
operating income55.00K-8.957M-3.911M-2.377M-4.209M
operating income ratio0.003-0.743-0.296-0.183-0.318
total other income expenses net-2.80M-3.871M-4.099M202.00K-1.299M
income before tax-2.745M-12.828M-8.01M-2.175M-5.508M
income before tax ratio-0.137-1.064-0.607-0.167-0.416
income tax expense0163.724K101.00K-140.00K284.00K
net income-2.745M-12.828M-8.111M-2.035M-5.792M
net income ratio-0.137-1.064-0.614-0.157-0.437
eps-0.03-0.17-0.12-0.032-0.10
eps diluted-0.03-0.17-0.12-0.032-0.10
weighted average shs out90.912M73.615M68.533M64.679M57.351M
weighted average shs out dil90.912M73.615M68.533M64.679M57.351M
Graph

AQST Balance Sheet


Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
cash and cash equivalents89.87M95.20M23.872M24.917M22.436M
short term investments00000
cash and short term investments89.87M95.20M23.872M24.917M22.436M
net receivables5.998M8.324M8.471M8.55M10.101M
inventory6.966M7.734M6.769M7.079M5.95M
other current assets1.177M2.121M1.854M1.911M1.301M
total current assets104.011M113.379M40.966M42.457M39.788M
property plant equipment net9.356M9.488M9.736M10.22M10.38M
goodwill00000
intangible assets01.239M1.278M1.317M1.357M
goodwill and intangible assets01.239M1.278M1.317M1.357M
long term investments3.00M4.00M4.00M4.00M4.00M
tax assets0-1.00-1.00-4.00M-4.00M
other non current assets1.238M1.417M1.438M5.454M5.469M
total non current assets13.594M16.144M16.452M16.991M17.206M
other assets01.001.0000
total assets117.605M129.523M57.418M59.448M56.994M
account payables5.696M10.523M8.926M9.994M10.689M
short term debt1.479M1.347M2.347M4.973M18.709M
tax payables382.00K433.00K337.00K377.00K299.00K
deferred revenue1.046M1.551M1.551M2.637M3.992M
other current liabilities5.674M4.637M5.484M6.453M5.263M
total current liabilities13.895M18.058M18.308M24.057M38.653M
long term debt110.167M108.504M91.076M40.064M26.411M
deferred revenue non current21.757M31.957M32.345M32.732M33.12M
deferred tax liabilities non current5.238M5.284M5.399M63.511M63.455M
other non current liabilities2.027M2.021M16.777M2.011M2.006M
total non current liabilities139.189M147.766M145.597M138.318M124.992M
other liabilities00000
capital lease obligations5.238M5.284M5.399M5.876M5.957M
total liabilities153.084M165.824M163.905M162.375M163.645M
preferred stock00000
common stock91.00K90.00K69.00K67.00K62.00K
retained earnings-334.65M-331.905M-319.077M-310.966M-308.931M
accumulated other comprehensive income loss00000
other total stockholders equity299.08M295.514M212.521M207.972M202.218M
total stockholders equity-35.479M-36.301M-106.487M-102.927M-106.651M
total equity-35.479M-36.301M-106.487M-102.927M-106.651M
total liabilities and stockholders equity117.605M129.523M57.418M59.448M56.994M
minority interest00000
total investments3.00M4.00M4.00M4.00M4.00M
total debt116.884M115.135M98.822M45.037M45.12M
net debt27.014M19.935M74.95M20.12M22.684M
Graph

AQST Cash Flow


A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-2.528M00
stock based compensation1.539M1.58M940.00K774.00K631.00K
change in working capital-8.361M-2.048M-1.10M-1.437M-3.087M
accounts receivables2.339M147.00K104.00K2.13M-1.675M
inventory768.00K-965.00K310.00K-1.129M1.031M
accounts payables-3.014M1.284M-1.068M-695.00K-1.751M
other working capital-8.454M-2.514M-446.00K-1.743M-692.00K
other non cash items4.212M4.233M5.39M88.00K52.00K
net cash provided by operating activities-7.006M-10.384M-4.942M-2.347M-7.907M
investments in property plant and equipment-35.00K-29.00K-16.00K-151.00K-826.00K
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites-35.00K-29.00K-16.00K-151.00K-826.00K
debt repayment-5.00K-5.00K-14.582M-1.022M-4.484M
common stock issued1.721M82.639M3.612M184.00K4.174M
common stock repurchased-5.00K-893.00K00-3.00K
dividends paid0000-3.00K
other financing activites-5.00K-893.00K14.883M5.817M4.603M
net cash used provided by financing activities1.711M81.741M3.913M4.979M4.287M
effect of forex changes on cash00000
net change in cash-5.33M71.328M-1.045M2.481M-4.446M
cash at end of period89.87M95.20M23.872M24.917M22.436M
cash at beginning of period95.20M23.872M24.917M22.436M26.882M
operating cashflow-7.006M-10.384M-4.942M-2.347M-7.907M
capital expenditure-35.00K-29.00K-16.00K-151.00K-826.00K
free cash flow-7.041M-10.413M-4.958M-2.498M-8.733M
Graph

Frequently Asked Questions

How did Aquestive Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, AQST generated $20.10M in revenue last quarter, while its costs came in at $4.53M.

Last quarter, how much Gross Profit did Aquestive Therapeutics, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Aquestive Therapeutics, Inc. reported a $15.57M Gross Profit for the quarter ended Jun 30, 2024.

Have AQST's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. AQST incurred $15.52M worth of Operating Expenses, while it generated $55.00K worth of Operating Income.

How much Net Income has AQST posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Aquestive Therapeutics, Inc., the company generated -$2.75M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Aquestive Therapeutics, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Aquestive Therapeutics, Inc. as of the end of the last quarter was $89.87M.

What are AQST's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, AQST had Total Net Receivables of $6.00M.

In terms of Total Assets and Current Assets, where did Aquestive Therapeutics, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of AQST were $104.01M, while the Total Assets stand at $117.61M.

As of the last quarter, how much Total Debt did Aquestive Therapeutics, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of AQST's debt was $116.88M at the end of the last quarter.

What were AQST's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, AQST reported total liabilities of $153.08M.

How much did AQST's Working Capital change over the last quarter?

Working Capital Change for AQST was -$8.36M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

AQST generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. AQST generated -$7.01M of Cash from Operating Activities during its recently reported quarter.

What was AQST's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. AQST reported a -$5.33M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Login Form

OR
stockstelegraph

Join to access AI-powered insights from top Wall Street analysts.

Signup Form

OR
stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Reset Password Form

stockstelegraph

Subscribe to gain access to powerful insights powered by AI and Wallstreet analysts.

This feature is only available to Premium Users.

Subscribe Now